{"id":17434,"date":"2026-06-05T10:59:01","date_gmt":"2026-06-05T13:59:01","guid":{"rendered":"https:\/\/www.biolabeco.com.br\/?post_type=imprensa&#038;p=17434"},"modified":"2026-06-15T10:59:52","modified_gmt":"2026-06-15T13:59:52","slug":"biolab-offers-medication-for-heart-failure","status":"publish","type":"imprensa","link":"https:\/\/www.biolabeco.com.br\/en\/imprensa\/biolab-oferta-medicamento-para-insuficiencia-cardiaca\/","title":{"rendered":"Biolab offers medication for heart failure"},"content":{"rendered":"<p><em>The condition affects 2 million Brazilians<\/em><\/p>\n\n\n\n<p>A&nbsp;<a href=\"https:\/\/panoramafarmaceutico.com.br\/tudo-sobre\/biolab\/\">Biolab Farmac\u00eautica<\/a>&nbsp;is expanding its presence in cardiology with the fixed-dose combination of sacubitril and valsartan. The drug joins the portfolio as a treatment option for approximately 2 million Brazilians living with&nbsp;<strong>heart failure (HF)<\/strong>, according to data from the Ministry of Health.<\/p>\n\n\n\n<p>The new treatment, which belongs to the class of INRAs (neprilysin and angiotensin receptor inhibitors), aims to reduce mortality and hospitalizations associated with the condition.\u00a0The therapy works in two ways: by relaxing blood vessels and eliminating excess fluid, thereby reducing the heart\u2019s workload.<\/p>\n\n\n\n<p>The launch in Brazil is the result of a strategic co-marketing partnership between Biolab and\u00a0<a href=\"https:\/\/panoramafarmaceutico.com.br\/tudo-sobre\/novartis\/\">Novartis<\/a>. The initiative combines the market strength and extensive reach of the Brazilian pharmaceutical group with the Swiss multinational\u2019s global expertise in innovation.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-insuficiencia-cardiaca-e-condicao-preocupante\">Heart failure is a serious condition<\/h2>\n\n\n\n<p>The situation in Brazil is critical, with&nbsp;<strong>the reporting of approximately 240,000 new cases annually<\/strong>. Characterized by the heart muscle\u2019s inability to pump blood with sufficient force, the condition imposes severe limitations on patients, such as shortness of breath, swelling, and extreme fatigue.&nbsp;<\/p>\n\n\n\n<p>Between 2011 and 2021, the\u00a0<a href=\"https:\/\/panoramafarmaceutico.com.br\/glossario\/sus-sistema-unico-de-saude\/\">SUS<\/a>\u00a0recorded more than 2.5 million hospitalizations for heart failure. Even so, the challenge persists after discharge: the prognosis remains concerning, with approximately 50% of patients being readmitted within 90 days.<\/p>\n\n\n\n<p>Read the full article: <a href=\"https:\/\/panoramafarmaceutico.com.br\/biolab-oferta-medicamento-para-insuficiencia-cardiaca\/\">Biolab offers medication for heart failure<\/a><\/p>","protected":false},"featured_media":17323,"template":"","categories":[1577],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.4 (Yoast SEO v24.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Biolab oferta medicamento para insufici\u00eancia card\u00edaca - Biolab &amp; Co<\/title>\n<meta name=\"description\" content=\"A\u00a0Biolab Farmac\u00eautica\u00a0amplia sua atua\u00e7\u00e3o em cardiologia com a combina\u00e7\u00e3o molecular de sacubitril e valsartana, como uma op\u00e7\u00e3o de tratamento para insufici\u00eancia card\u00edaca (IC).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biolabeco.com.br\/en\/press\/biolab-offers-medication-for-heart-failure\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biolab oferta medicamento para insufici\u00eancia card\u00edaca\" \/>\n<meta property=\"og:description\" content=\"A\u00a0Biolab Farmac\u00eautica\u00a0amplia sua atua\u00e7\u00e3o em cardiologia com a combina\u00e7\u00e3o molecular de sacubitril e valsartana, como uma op\u00e7\u00e3o de tratamento para insufici\u00eancia card\u00edaca (IC).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biolabeco.com.br\/en\/press\/biolab-offers-medication-for-heart-failure\/\" \/>\n<meta property=\"og:site_name\" content=\"Biolab &amp; Co\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-15T13:59:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/06\/BiolabCo-Farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca-foto-shutterstock.jpg.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1800\" \/>\n\t<meta property=\"og:image:height\" content=\"1013\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-oferta-medicamento-para-insuficiencia-cardiaca\/\",\"url\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-oferta-medicamento-para-insuficiencia-cardiaca\/\",\"name\":\"Biolab oferta medicamento para insufici\u00eancia card\u00edaca - Biolab &amp; Co\",\"isPartOf\":{\"@id\":\"https:\/\/www.biolabeco.com.br\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-oferta-medicamento-para-insuficiencia-cardiaca\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-oferta-medicamento-para-insuficiencia-cardiaca\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/06\/BiolabCo-Farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca-foto-shutterstock.jpg.jpeg\",\"datePublished\":\"2026-06-05T13:59:01+00:00\",\"dateModified\":\"2026-06-15T13:59:52+00:00\",\"description\":\"A\u00a0Biolab Farmac\u00eautica\u00a0amplia sua atua\u00e7\u00e3o em cardiologia com a combina\u00e7\u00e3o molecular de sacubitril e valsartana, como uma op\u00e7\u00e3o de tratamento para insufici\u00eancia card\u00edaca (IC).\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-oferta-medicamento-para-insuficiencia-cardiaca\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-oferta-medicamento-para-insuficiencia-cardiaca\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-oferta-medicamento-para-insuficiencia-cardiaca\/#primaryimage\",\"url\":\"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/06\/BiolabCo-Farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca-foto-shutterstock.jpg.jpeg\",\"contentUrl\":\"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/06\/BiolabCo-Farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca-foto-shutterstock.jpg.jpeg\",\"width\":1800,\"height\":1013,\"caption\":\"L\u00edder em cardiologia, farmac\u00eautica passa a oferecer medicamento para condi\u00e7\u00e3o que afeta 2 milh\u00f5es de brasileiros\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-oferta-medicamento-para-insuficiencia-cardiaca\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biolabeco.com.br\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biolab oferta medicamento para insufici\u00eancia card\u00edaca\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biolabeco.com.br\/#website\",\"url\":\"https:\/\/www.biolabeco.com.br\/\",\"name\":\"Biolab\",\"description\":\"Na Biolab &amp; Co, ci\u00eancia e cuidado caminham juntos. Saiba como promovemos sa\u00fade com responsabilidade socioambiental e tecnologia.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biolabeco.com.br\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Biolab offers medication for heart failure - Biolab &amp; Co","description":"Biolab Farmac\u00eautica is expanding its presence in cardiology with the molecular combination of sacubitril and valsartan, as a treatment option for heart failure (HF).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biolabeco.com.br\/en\/press\/biolab-offers-medication-for-heart-failure\/","og_locale":"en_US","og_type":"article","og_title":"Biolab oferta medicamento para insufici\u00eancia card\u00edaca","og_description":"A\u00a0Biolab Farmac\u00eautica\u00a0amplia sua atua\u00e7\u00e3o em cardiologia com a combina\u00e7\u00e3o molecular de sacubitril e valsartana, como uma op\u00e7\u00e3o de tratamento para insufici\u00eancia card\u00edaca (IC).","og_url":"https:\/\/www.biolabeco.com.br\/en\/press\/biolab-offers-medication-for-heart-failure\/","og_site_name":"Biolab &amp; Co","article_modified_time":"2026-06-15T13:59:52+00:00","og_image":[{"width":1800,"height":1013,"url":"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/06\/BiolabCo-Farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca-foto-shutterstock.jpg.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-oferta-medicamento-para-insuficiencia-cardiaca\/","url":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-oferta-medicamento-para-insuficiencia-cardiaca\/","name":"Biolab offers medication for heart failure - Biolab &amp; Co","isPartOf":{"@id":"https:\/\/www.biolabeco.com.br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-oferta-medicamento-para-insuficiencia-cardiaca\/#primaryimage"},"image":{"@id":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-oferta-medicamento-para-insuficiencia-cardiaca\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/06\/BiolabCo-Farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca-foto-shutterstock.jpg.jpeg","datePublished":"2026-06-05T13:59:01+00:00","dateModified":"2026-06-15T13:59:52+00:00","description":"Biolab Farmac\u00eautica is expanding its presence in cardiology with the molecular combination of sacubitril and valsartan, as a treatment option for heart failure (HF).","breadcrumb":{"@id":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-oferta-medicamento-para-insuficiencia-cardiaca\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biolabeco.com.br\/imprensa\/biolab-oferta-medicamento-para-insuficiencia-cardiaca\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-oferta-medicamento-para-insuficiencia-cardiaca\/#primaryimage","url":"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/06\/BiolabCo-Farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca-foto-shutterstock.jpg.jpeg","contentUrl":"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2026\/06\/BiolabCo-Farmaceutica-amplia-portfolio-com-terapia-para-insuficiencia-cardiaca-foto-shutterstock.jpg.jpeg","width":1800,"height":1013,"caption":"L\u00edder em cardiologia, farmac\u00eautica passa a oferecer medicamento para condi\u00e7\u00e3o que afeta 2 milh\u00f5es de brasileiros"},{"@type":"BreadcrumbList","@id":"https:\/\/www.biolabeco.com.br\/imprensa\/biolab-oferta-medicamento-para-insuficiencia-cardiaca\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biolabeco.com.br\/"},{"@type":"ListItem","position":2,"name":"Biolab oferta medicamento para insufici\u00eancia card\u00edaca"}]},{"@type":"WebSite","@id":"https:\/\/www.biolabeco.com.br\/#website","url":"https:\/\/www.biolabeco.com.br\/","name":"Biolab","description":"At Biolab &amp; Co, science and care go hand in hand. Find out how we promote health with social and environmental responsibility and technology.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biolabeco.com.br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/imprensa\/17434"}],"collection":[{"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/imprensa"}],"about":[{"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/types\/imprensa"}],"version-history":[{"count":1,"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/imprensa\/17434\/revisions"}],"predecessor-version":[{"id":17435,"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/imprensa\/17434\/revisions\/17435"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/media\/17323"}],"wp:attachment":[{"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/media?parent=17434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/categories?post=17434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}